共 7 条
[1]
Lurasidone: a new drug in development for schizophrenia[J] . Jonathan M Meyer,Antony D Loebel,Edward Schweizer.Expert Opinion on Investigational Drugs . 2009 (11)
[2]
Performance-Based Measurement of Functional Disability in Schizophrenia: A Cross-National Study in the United States and Sweden[J] . Harvey,Philip D,Helldin,Lars,Bowie,Christopher R,Heaton,Robert K,Olsson,Anna-Karin,Hj?rthag,Fredrik,Norlander,Torsten,Patterson,Thomas L.The American Journal of Psychiatry . 2009 (7)
[3]
Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures
[J].
BIOLOGICAL PSYCHIATRY,
2008, 63 (05)
:505-511
Bowie, Christopher R.
;
Leung, Winnie W.
;
Reichenberg, Abraham
;
McClure, Margaret M.
;
Patterson, Thomas L.
;
Heaton, Robert K.
;
Harvey, Philip D.
.
[4]
The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and Standardization[J] . Kern,Robert S,Nuechterlein,Keith H,Green,Michael F,Baade,Lyle E,Fenton,Wayne S,Gold,James M,Keefe,Richard S E,Mesholam-Gately,Raquelle,Mintz,Jim,Seidman,Larry J,Stover,Ellen,Marder,Stephen R.The American Journal of Psychiatry . 2008 (2)
[5]
UCSD Performance-Based Skills Assessment: Development of a New Measure of Everyday Functioning for Severely Mentally Ill Adults[J] . Thomas L. Patterson,Sherry Goldman,Christine L. McKibbin,Troy Hughs,Dilip V. Jeste.Schizophrenia Bulletin . 2001 (2)
[6]
A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia[J] . D. P. van Kammen,J. P. McEvoy,S. D. Targum,D. Kardatzke,T. B. Sebree.Psychopharmacology . 1996 (1)
[7]
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments .2 RW Buchanan,DC Javitt,SR Marder,NR Schooler,JM Gold,RP McMahon. Am J Psychiatry . 2007